HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination. [electronic resource]
- PloS one 2018
- e0204795 p. digital
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0204795 doi
Adult Cohort Studies Female Harm Reduction--physiology Hepacivirus--immunology Hepatitis C--etiology Hepatitis C Antibodies--immunology Humans Incidence Male Methadone--administration & dosage Mobile Health Units Seroconversion--physiology Substance Abuse, Intravenous--complications